108 related articles for article (PubMed ID: 10372141)
1. Canine lymphocyte expression of retrovirally transferred human common gamma chain.
Whitwam T; Haskins ME; Henthorn PS; Bodine DM; Puck JM
Ann N Y Acad Sci; 1999 Apr; 872():387-90. PubMed ID: 10372141
[No Abstract] [Full Text] [Related]
2. Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes.
Whitwam T; Haskins ME; Henthorn PS; Kraszewski JN; Kleiman SE; Seidel NE; Bodine DM; Puck JM
Blood; 1998 Sep; 92(5):1565-75. PubMed ID: 9716584
[TBL] [Abstract][Full Text] [Related]
3. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID).
Leonard WJ; Noguchi M; Russell SM
Adv Exp Med Biol; 1994; 365():225-32. PubMed ID: 7887307
[No Abstract] [Full Text] [Related]
4. Three novel mutations in the interleukin-2 receptor gamma chain gene in four Japanese patients with X-linked severe combined immunodeficiency.
Minegishi Y; Ishii N; Maeda H; Takagi S; Tsuchida M; Okawa H; Sugamura K; Yata J
Hum Genet; 1995 Dec; 96(6):681-3. PubMed ID: 8522327
[TBL] [Abstract][Full Text] [Related]
5. Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.
Ting-De Ravin SS; Kennedy DR; Naumann N; Kennedy JS; Choi U; Hartnett BJ; Linton GF; Whiting-Theobald NL; Moore PF; Vernau W; Malech HL; Felsburg PJ
Blood; 2006 Apr; 107(8):3091-7. PubMed ID: 16384923
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide insertion in the canine interleukin-2 receptor gamma chain results in X-linked severe combined immunodeficiency disease.
Somberg RL; Pullen RP; Casal ML; Patterson DF; Felsburg PJ; Henthorn PS
Vet Immunol Immunopathol; 1995 Aug; 47(3-4):203-13. PubMed ID: 8571541
[TBL] [Abstract][Full Text] [Related]
7. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
Puck JM; Deschênes SM; Porter JC; Dutra AS; Brown CJ; Willard HF; Henthorn PS
Hum Mol Genet; 1993 Aug; 2(8):1099-104. PubMed ID: 8401490
[TBL] [Abstract][Full Text] [Related]
8. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach.
Lo M; Bloom ML; Imada K; Berg M; Bollenbacher JM; Bloom ET; Kelsall BL; Leonard WJ
Blood; 1999 Nov; 94(9):3027-36. PubMed ID: 10556186
[TBL] [Abstract][Full Text] [Related]
9. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
10. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency.
Candotti F; Johnston JA; Puck JM; Sugamura K; O'Shea JJ; Blaese RM
Blood; 1996 Apr; 87(8):3097-102. PubMed ID: 8605322
[TBL] [Abstract][Full Text] [Related]
11. 'Bubble boy' paradox resolved.
Nowak R
Science; 1993 Dec; 262(5141):1818. PubMed ID: 8266068
[No Abstract] [Full Text] [Related]
12. Genetic therapy using bone marrow transplantation.
Giles RE; Hanania EG; Fu S; Deisseroth A
Cancer Treat Res; 1995; 76():271-80. PubMed ID: 7577339
[No Abstract] [Full Text] [Related]
13. Canine X-linked severe combined immunodeficiency. A model for investigating the requirement for the common gamma chain (gamma c) in human lymphocyte development and function.
Felsburg PJ; Somberg RL; Hartnett BJ; Henthorn PS; Carding SR
Immunol Res; 1998; 17(1-2):63-73. PubMed ID: 9479568
[TBL] [Abstract][Full Text] [Related]
14. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.
Stephan V; Wahn V; Le Deist F; Dirksen U; Broker B; Müller-Fleckenstein I; Horneff G; Schroten H; Fischer A; de Saint Basile G
N Engl J Med; 1996 Nov; 335(21):1563-7. PubMed ID: 8900089
[No Abstract] [Full Text] [Related]
15. T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient.
Morelon E; Dautry-Varsat A; Le Deist F; Hacein-Bay S; Fischer A; de Saint Basile G
Blood; 1996 Sep; 88(5):1708-17. PubMed ID: 8781427
[TBL] [Abstract][Full Text] [Related]
16. Harvey murine sarcoma virus/MDR1 retroviral vectors: efficient virus production and foreign gene transduction using MDR1 as a selectable marker.
Metz MZ; Best DM; Kane SE
Virology; 1995 Apr; 208(2):634-43. PubMed ID: 7747435
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the gammac chain among 27 unrelated Japanese patients with X-linked severe combined immunodeficiency (X-SCID).
Kumaki S; Ishii N; Minegishi M; Ohashi Y; Hakozaki I; Nonoyama S; Imai K; Morio T; Tsuge I; Sakiyama Y; Miyanoshita A; Miura J; Mayumi M; Heike T; Katamura K; Takada H; Izumi I; Kamizono J; Hibi S; Sasaki H; Kimura M; Kikuta A; Date Y; Sako M; Tanaka H; Sano K; Sugamura K; Tsuchiya S
Hum Genet; 2000 Oct; 107(4):406-8. PubMed ID: 11129345
[TBL] [Abstract][Full Text] [Related]
18. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
Puck JM; Pepper AE; Bédard PM; Laframboise R
J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
[TBL] [Abstract][Full Text] [Related]
19. [Gene therapy of severe combined immunodeficiencies].
Cavazzana-Calvo M; Hacein-Bey S; de Saint-Basile G; Le Deist F; Fischer A
Transfus Clin Biol; 2000 Jun; 7(3):259-60. PubMed ID: 10919216
[No Abstract] [Full Text] [Related]
20. Efficacy of gene therapy for SCID is being confirmed.
Cavazzana-Calvo M; Fischer A
Lancet; 2004 Dec 18-31; 364(9452):2155-6. PubMed ID: 15610783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
